RISKS OF ISONIAZID THERAPY

被引：3

作者：

BROWN, A ^{[1
]}

机构：

[1] VET ADM HOSP, PITTSBURGH, PA 15240 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1976年 / 85卷 / 06期

关键词：

D O I：

10.7326/0003-4819-85-6-828

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：828 / 829

页数：2

共 6 条

[1]

BLACK M, 1975, GASTROENTEROLOGY, V69, P289

[2] ISONIAZID HEPATITIS [J].

MADDREY, WC ;

BOITNOTT, JK .

ANNALS OF INTERNAL MEDICINE, 1973, 79 (01) :1-12

[3] ISONIAZID LIVER-INJURY - CLINICAL SPECTRUM, PATHOLOGY, AND PROBABLE PATHOGENESIS [J].

MITCHELL, JR ;

ZIMMERMAN, HJ ;

ISHAK, KG ;

THORGEIRSSON, UP ;

TIMBRELL, JA ;

SNODGRASS, WR ;

NELSON, SD .

ANNALS OF INTERNAL MEDICINE, 1976, 84 (02) :181-192

[4]

MITCHELL JR, 1975, CLIN PHARMACOL THER, V18, P70

[5] ACETYLATION RATES AND MONTHLY LIVER-FUNCTION TESTS DURING ONE YEAR OF ISONIAZID PREVENTIVE THERAPY [J].

MITCHELL, JR ;

LONG, MW ;

THORGEIRSSON, UP ;

JOLLOW, JD .

CHEST, 1975, 68 (02) :181-190

[6] HEPATOTOXICITY IN RIFAMPIN-ISONIAZID TREATED PATIENTS RELATED TO THEIR RATE OF ISONIAZID INACTIVATION [J].

SMITH, J ;

TYRRELL, WF ;

ALLAN, GW ;

LEES, AW ;

GOW, A .

CHEST, 1972, 61 (06) :587-&

← 1 →